Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

Cancer Research UK launches medicine manufacturing hub for life-saving research

Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody...

Study points to potential new treatment for deadly pancreatic cancer

New research shows how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer.

DNA sequencing matches cancer patients to clinical trials

High-tech DNA scanning machines could help identify cancer patients' individual genetic make-up to match them to appropriate clinical trials, according to scientists in...

Scientists crack the code to tamoxifen resistance

Scientists crack the code to tamoxifen resistance

Blocking key cell component could make 'smart drugs' effective for many cancer patients

Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could...

CRT and AstraZeneca form major alliance to create cancer metabolism drugs

Cancer Research UKїs commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca...

Sea sponge drug may extend advanced breast cancer survival

A new drug, based on a natural extract from sea sponge, may help to extend the lives of women with advanced breast cancer, UK scientists have found.

Surprising discovery could help scientists refine treatment for advanced melanoma

A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer...

CRT, Newcastle University and KuDOS advance DNA-PK research with a new licence

Cancer Research Technology Limited (CRT) has licensed the rights to its DNA-dependent protein kinase (DNA-PK)* inhibitor programme to collaboration partner KuDOS...

Master switch’ experimental drug could treat different cancers

A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today.

Pages